Cantabria Labs targets 300 million euro turnover in 2023
The Spanish pharmaceutical company closes 2021 with 24% growth. Presenting the company’s evolution in 2021 and its plans for 2022, Cantabria Labs CEO Susana Rodríguez reported that the pharmaceutical company grew by 24% over the last 12 months, although final year-end results are not yet available. 2021 also featured positive net employment, with the company […]